Boston, MA -- (SBWIRE) -- 09/02/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Halozyme Therapeutics, Inc.(NASDAQ:HALO), Fusion-IO, Inc.(NYSE:FIO), Amkor Technology, Inc.(NASDAQ:AMKR), Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX)
Halozyme Therapeutics, Inc.(NASDAQ:HALO) increased+0.73 % and closed at $8.31 on a traded volume of 1.39 million shares, in comparison to 1.45 million shares of average trading volume. So far this year, the stock is over +23.85%.
The company has a total market capitalization of $941.40 million and its total outstanding shares are 113.29 million. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and fluids, or to alter abnormal tissue structures for clinical benefit.
For How Long HALO will Fight for Profitability? Read This Trend Analysis report
Fusion-IO, Inc.(NYSE:FIO) plunged -1.38% and closed at $10.69 on a traded volume of1.38 million shares, whereas its average trading volume is 3.66 million shares. In the last three months, the stock is down -26.12%. The Intra-day range for the stock is $10.50 and $10.82. Fusion-io, Inc. engages in the development, marketing, and sale of storage memory platforms for enterprise data decentralization primarily in the United States. Its integrated hardware and software platform enables the decentralization of data from legacy architectures and specialized hardware.
Has FIO Found The Bottom And Ready To Gain Momentum? Find Out Here
Amkor Technology, Inc.(NASDAQ:AMKR) dropped down -3.14% and closed at $4.01. So far in three months, the stock is down -11.67%. The 52-week range for the stock is $3.55 and $5.04 and during the previous trading session the stock touched its highest price at $4.15. Its introductory price for the day was $4.13, with the overall traded volume of 1.41 million shares. Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States and internationally. The company operates in two segments, Packaging and Test.
Why Should Investors Buy AMKR After the Recent Fall? Just Go Here and Find Out
Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX), after opening its shares at the price of $1.96, jumped up 5.6% to close at $1.94 for the day. The stock moved on a traded volume of 1.38 million shares, in comparison to 2.61 million shares of average trading volume.
The 52-week range for the stock is $0.37 and $2.50 and during the previous trading session the stock touched its highest price at $1.98. Its introductory price for the day was $1.96. Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company?s principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome.
Why Should Investors Buy CPRX After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)